What prescription should be written for an end‑stage renal disease (ESRD) patient on hemodialysis twice weekly who is a smoker?

Prescription for ESRD Patient on Twice-Weekly Hemodialysis Who Smokes

For an ESRD patient on twice-weekly hemodialysis, prescribe medications immediately after dialysis sessions, adjust all renally-cleared drugs to three-times-weekly dosing (not daily), provide intensive iron supplementation, optimize anemia management with erythropoietin, and implement aggressive smoking cessation therapy.

Medication Timing and Administration

All medications should be administered immediately after hemodialysis sessions to facilitate directly observed therapy and avoid premature drug removal during dialysis 1. For twice-weekly dialysis, this creates a critical medication timing framework.

Essential Medications by Category

1. Anemia Management

• Erythropoietin (Epoetin): Administer subcutaneously 2-3 times per week at 50-150 units/kg per dose 2

  • Subcutaneous route is 15-50% more efficient than IV administration 2
  • Target hemoglobin: 11-12 g/dL (Hct 33-36%) 2
  • Give after dialysis on dialysis days

• Intravenous Iron: 100-125 mg after each dialysis session for 8-10 doses initially 2

  • Maintenance: 25-125 mg weekly to provide 250-1,000 mg within 12 weeks 2
  • Monitor TSAT and ferritin every 3 months
  • Target: TSAT >20%, ferritin >100 ng/mL 2

2. Bone and Mineral Metabolism

• Active Vitamin D Sterol (if intact PTH >300 pg/mL):

  • Calcitriol 0.5-1.0 mcg OR Doxercalciferol 2.5-5.0 mcg, given 2-3 times weekly after dialysis 3
  • Target PTH: 150-300 pg/mL 3
  • Monitor calcium and phosphorus every 2 weeks for 1 month, then monthly 3

• Phosphate Binders: Calcium-based binders with meals

  • Adjust based on serum phosphorus levels (target <4.6 mg/dL) 3

3. Cardiovascular Management

• Antihypertensive Therapy:

  • ACE inhibitors or ARBs are preferred for LVH regression and cardiovascular protection 4, 5
  • For twice-weekly dialysis: Lisinopril or atenolol can be given after each dialysis session due to prolonged half-life in ESRD 5
  • Alternative: Transdermal clonidine once weekly for compliance issues 5
  • Target: Pre-dialysis BP <140/90 mmHg, post-dialysis <130/80 mmHg 4

• Statin Therapy:

  • Atorvastatin or fluvastatin (no dose adjustment needed in ESRD) 6
  • These are hepatically cleared, avoiding renal accumulation 6

4. Smoking Cessation (Critical Priority)

Smoking is a significant risk factor for dialysis access failure, cardiovascular events, and mortality 7, 4. Prescribe:

• Nicotine replacement therapy: Patches, gum, or lozenges (no dose adjustment needed)
• Varenicline: Reduce dose to 0.5 mg once daily (renally cleared)
• Bupropion: 150 mg once daily (avoid twice-daily dosing in ESRD)
• Provide intensive counseling at every dialysis session 4

5. Adjuvant Pharmacotherapy for Twice-Weekly Dialysis

Based on recent evidence for incremental dialysis 8:

• Loop Diuretics: Furosemide 40-80 mg twice daily (if urine output >500 mL/day)

  • Helps maintain residual renal function
  • 100% of twice-weekly patients require this 8

• Sodium Bicarbonate: 650-1300 mg three times daily (if metabolic acidosis present)

  • Prescribed in 39% of twice-weekly patients 8

• Patiromer: 8.4-16.8 g daily (if hyperkalemia develops)

  • Prescribed in 17% of twice-weekly patients 8

Medications to AVOID

• Aminoglycosides and tetracyclines: Nephrotoxic 7
• Nitrofurantoin: Causes peripheral neuritis 7
• Daily dosing of renally-cleared drugs: Must convert to post-dialysis dosing 1

Monitoring Schedule

• Weekly: Blood pressure, weight, interdialytic weight gain
• Every 2 weeks (first month of vitamin D): Calcium, phosphorus
• Monthly: Hemoglobin, PTH (first 3 months), then every 3 months
• Every 3 months: TSAT, ferritin, PTH (after stabilization), lipid panel

Critical Pitfalls to Avoid

1. Never prescribe daily dosing for renally-cleared medications - convert to 2-3 times weekly after dialysis 1
2. Do not withhold iron due to "normal" ferritin - most dialysis patients need regular IV iron to maintain Hgb targets 2
3. Avoid excessive vitamin D if calcium >9.5 mg/dL or phosphorus >4.6 mg/dL - hold therapy and restart at half dose 3
4. Monitor for hyperkalemia closely with twice-weekly dialysis - longer interdialytic intervals increase risk 8
5. Preserve peripheral veins - avoid venipuncture in non-dominant arm for future access 9

Quality of Life Considerations

Twice-weekly dialysis with adequate Kt/V (target ≥2.0) can provide acceptable quality of life if properly monitored 10. However, plan transition to thrice-weekly dialysis if:

• Urine output drops below 500 mL/day
• Hyperkalemia becomes unmanageable
• Volume overload develops
• Uremic symptoms emerge